Three European countries on Thursday said they would hold off on resuming usage of the Oxford-AstraZeneca COVID-19 vaccine even after the bloc’s drug regulator said the benefits of the vaccine outweigh the negative side effects and cleared it for use.
Denmark, Norway, and Sweden, in separate statements, said they would wait on whether to decide if they would resume rolling out the vaccine.
